Candriam Equities L Biotechnology Class R GBP CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/10/2024 |
|
Annual Returns (GBP) | 31/10/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/10 | |
Price Return | 16.63 | -5.01 | 30.77 | 16.46 | -1.00 | 11.79 | 2.00 | 9.71 |
+/- Category | 6.34 | 2.96 | 10.57 | -9.50 | 8.04 | 19.63 | 3.29 | 8.25 |
+/- Category Index | 1.44 | -3.16 | 14.06 | -16.47 | -1.29 | 9.33 | -5.33 | 3.90 |
% Rank in Category | 20 | 33 | 8 | 69 | 34 | 1 | 29 | 10 |
Trailing Returns (GBP) | 20/11/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.87 | -0.26 | 1.09 |
1 Week | -6.03 | 0.68 | -2.73 |
1 Month | -6.06 | -0.74 | 1.67 |
3 Months | -5.22 | -1.59 | 8.39 |
6 Months | 5.21 | 5.86 | 14.14 |
YTD | 6.60 | 7.87 | 5.79 |
1 Year | 21.19 | 7.43 | 14.50 |
3 Years Annualised | 6.40 | 11.59 | 4.49 |
5 Years Annualised | 8.05 | 3.14 | -0.50 |
10 Years Annualised* | 8.92 | 1.54 | 0.66 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/10/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.95 | 2.96 | -0.30 | - |
2023 | -5.15 | 0.12 | -1.13 | 8.64 |
2022 | -3.81 | 0.13 | 13.67 | 2.12 |
2021 | -5.80 | 6.81 | 0.61 | -2.20 |
2020 | -5.16 | 25.26 | -5.69 | 3.95 |
2019 | 14.08 | 1.91 | -5.67 | 19.24 |
|
Advertisement |